Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma
{{output}}
Proteasome inhibitors (PIs) are cornerstone therapies for multiple myeloma (MM), yet resistance remains a major barrier to durable responses. To identify druggable vulnerabilities that enhance PI efficacy, we performed a small-molecule chemical screen in the p... ...
